Literature DB >> 15604149

Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease.

Navin Maswood1, Jennifer Young, Edward Tilmont, Zhiming Zhang, Don M Gash, Greg A Gerhardt, Richard Grondin, George S Roth, Julie Mattison, Mark A Lane, Richard E Carson, Robert M Cohen, Peter R Mouton, Christopher Quigley, Mark P Mattson, Donald K Ingram.   

Abstract

We report that a low-calorie diet can lessen the severity of neurochemical deficits and motor dysfunction in a primate model of Parkinson's disease. Adult male rhesus monkeys were maintained for 6 months on a reduced-calorie diet [30% caloric restriction (CR)] or an ad libitum control diet after which they were subjected to treatment with a neurotoxin to produce a hemiparkinson condition. After neurotoxin treatment, CR monkeys exhibited significantly higher levels of locomotor activity compared with control monkeys as well as higher levels of dopamine (DA) and DA metabolites in the striatal region. Increased survival of DA neurons in the substantia nigra and improved manual dexterity were noted but did not reach statistical significance. Levels of glial cell line-derived neurotrophic factor, which is known to promote the survival of DA neurons, were increased significantly in the caudate nucleus of CR monkeys, suggesting a role for glial cell line-derived neurotrophic factor in the anti-Parkinson's disease effect of the low-calorie diet.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15604149      PMCID: PMC539733          DOI: 10.1073/pnas.0405831102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  R Moratalla; B Quinn; L E DeLanney; I Irwin; J W Langston; A M Graybiel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

Review 2.  Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging.

Authors:  R Weindruch; R S Sohal
Journal:  N Engl J Med       Date:  1997-10-02       Impact factor: 91.245

Review 3.  Cellular and molecular mechanisms of impaired dopaminergic function during aging.

Authors:  G S Roth; J A Joseph
Journal:  Ann N Y Acad Sci       Date:  1994-05-31       Impact factor: 5.691

4.  6-[18F]fluoro-L-m-tyrosine: metabolism, positron emission tomography kinetics, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lesions in primates.

Authors:  S Jordan; J L Eberling; K S Bankiewicz; D Rosenberg; P G Coxson; H F VanBrocklin; J P O'Neil; M E Emborg; W J Jagust
Journal:  Brain Res       Date:  1997-03-07       Impact factor: 3.252

Review 5.  Neurobiological bases of age-related cognitive decline in the rhesus monkey.

Authors:  A Peters; D L Rosene; M B Moss; T L Kemper; C R Abraham; J Tigges; M S Albert
Journal:  J Neuropathol Exp Neurol       Date:  1996-08       Impact factor: 3.685

6.  Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.

Authors:  D M Frim; T A Uhler; W R Galpern; M F Beal; X O Breakefield; O Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

7.  Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys.

Authors:  A Ovadia; Z Zhang; D M Gash
Journal:  Neurobiol Aging       Date:  1995 Nov-Dec       Impact factor: 4.673

8.  Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study.

Authors:  G Logroscino; K Marder; L Cote; M X Tang; S Shea; R Mayeux
Journal:  Ann Neurol       Date:  1996-01       Impact factor: 10.422

9.  Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys.

Authors:  T Tsukahara; M Takeda; S Shimohama; O Ohara; N Hashimoto
Journal:  Neurosurgery       Date:  1995-10       Impact factor: 4.654

10.  Functional recovery in parkinsonian monkeys treated with GDNF.

Authors:  D M Gash; Z Zhang; A Ovadia; W A Cass; A Yi; L Simmerman; D Russell; D Martin; P A Lapchak; F Collins; B J Hoffer; G A Gerhardt
Journal:  Nature       Date:  1996-03-21       Impact factor: 49.962

View more
  140 in total

1.  Dietary restriction mitigates cocaine-induced alterations of olfactory bulb cellular plasticity and gene expression, and behavior.

Authors:  Xiangru Xu; Mohamed R Mughal; F Scott Hall; Maria T G Perona; Paul J Pistell; Justin D Lathia; Srinivasulu Chigurupati; Kevin G Becker; Bruce Ladenheim; Laura E Niklason; George R Uhl; Jean Lud Cadet; Mark P Mattson
Journal:  J Neurochem       Date:  2010-04-29       Impact factor: 5.372

2.  A calorie-restricted diet decreases brain iron accumulation and preserves motor performance in old rhesus monkeys.

Authors:  Erik K Kastman; Auriel A Willette; Christopher L Coe; Barbara B Bendlin; Kris J Kosmatka; Donald G McLaren; Guofan Xu; Elisa Canu; Aaron S Field; Andrew L Alexander; Mary Lou Voytko; T Mark Beasley; Ricki J Colman; Richard H Weindruch; Sterling C Johnson
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

3.  Caloric restriction improves memory in elderly humans.

Authors:  A V Witte; M Fobker; R Gellner; S Knecht; A Flöel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

Review 4.  Glutamate and neurotrophic factors in neuronal plasticity and disease.

Authors:  Mark P Mattson
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

5.  Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.

Authors:  Marianna Sikorska; Patricia Lanthier; Harvey Miller; Melissa Beyers; Caroline Sodja; Bogdan Zurakowski; Sandhya Gangaraju; Siyaram Pandey; Jagdeep K Sandhu
Journal:  Neurobiol Aging       Date:  2014-04-02       Impact factor: 4.673

6.  Dietary restriction enhances kainate-induced increase in NCAM while blocking the glial activation in adult rat brain.

Authors:  Sandeep Sharma; Gurcharan Kaur
Journal:  Neurochem Res       Date:  2007-11-10       Impact factor: 3.996

7.  Circulating factors induced by caloric restriction in the nonhuman primate Macaca mulatta activate angiogenic processes in endothelial cells.

Authors:  Anna Csiszar; Danuta Sosnowska; Zsuzsanna Tucsek; Tripti Gautam; Peter Toth; Gyorgy Losonczy; Ricki J Colman; Richard Weindruch; Rozalyn M Anderson; William E Sonntag; Zoltan Ungvari
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-08-17       Impact factor: 6.053

Review 8.  Neurotrophic factors in neurodegenerative disorders : potential for therapy.

Authors:  Fabio Fumagalli; Raffaella Molteni; Francesca Calabrese; Paola Francesca Maj; Giorgio Racagni; Marco Andrea Riva
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  The ketogenic diet: uses in epilepsy and other neurologic illnesses.

Authors:  Kristin W Barañano; Adam L Hartman
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

10.  Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism.

Authors:  Zane B Andrews; Derek Erion; Rudolph Beiler; Zhong-Wu Liu; Alfonso Abizaid; Jeffrey Zigman; John D Elsworth; Joseph M Savitt; Richard DiMarchi; Matthias Tschoep; Robert H Roth; Xiao-Bing Gao; Tamas L Horvath
Journal:  J Neurosci       Date:  2009-11-11       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.